Triacylglycerol synthesis enhances macrophage inflammatory function

Abstract

Foamy macrophages, which have prominent lipid droplets (LDs), are found in a variety of disease states. Toll-like receptor agonists drive triacylglycerol (TG)-rich LD development in macrophages. Here we explore the basis and significance of this process. Our findings indicate that LD development is the result of metabolic commitment to TG synthesis on a background of decreased fatty acid oxidation. TG synthesis is essential for optimal inflammatory macrophage activation as its inhibition, which prevents LD development, has marked effects on the production of inflammatory mediators, including IL-1β, IL-6 and PGE2, and on phagocytic capacity. The failure of inflammatory macrophages to make PGE2 when TG-synthesis is inhibited is critical for this phenotype, as addition of exogenous PGE2 is able to reverse the anti-inflammatory effects of TG synthesis inhibition. These findings place LDs in a position of central importance in inflammatory macrophage activation.

References 51

1. 1.

   Guerrini V, Gennaro ML. Foam cells: one size doesn’t fit all. Trends Immunol. 2019.

   Not in our library10.1016/j.it.2019.10.002

2. 2.

   Thiam AR, Farese RV, Walther TC. The biophysics and cell biology of lipid droplets. Nat. Rev. Mol. Cell Biol. 2013;14:775-786.

   Not in our library10.1038/nrm3699

3. 3.

   Huang YL, et al. Toll-like receptor agonists promote prolonged triglyceride storage in macrophages. J. Biol. Chem. 2014;289:3001-3012.

   Not in our library10.1074/jbc.m113.524587

4. 4.

   Huang SC, et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 2014;15:846-855.

   Not in our library10.1038/ni.2956

5. 5.

   Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720-3732.

   Not in our library10.1182/blood-2010-07-273417

6. 6.

   O’Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 2016;213:15-23.

   Not in our library10.1084/jem.20151570

7. 7.

   Jha AK, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42:419-430.

   Not in our library10.1016/j.immuni.2015.02.005

8. 8.

   Dennis EA, et al. A mouse macrophage lipidome. J. Biol. Chem. 2010;285:39976-39985.

   Not in our library10.1074/jbc.m110.182915

9. 9.

   Funk JL, Feingold KR, Moser AH, Grunfeld C. Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis. 1993;98:67-82.

   Not in our library10.1016/0021-9150(93)90224-i

10. 10.

    Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 2008;49:2283-2301.

    Not in our library10.1194/jlr.r800018-jlr200

11. 11.

    Henne, W. M., Reese, M. L. & Goodman, J. M. The assembly of lipid droplets and their roles in challenged cells. EMBO J. 37, 10.15252/embj.201898947 (2018).

    Not in our library10.15252/embj.201898947

12. 12.

    Chitraju C, et al. Triglyceride synthesis by DGAT1 protects adipocytes from lipid-induced ER stress during lipolysis. Cell Metab. 2017;26:407-418.e403.

    Not in our library10.1016/j.cmet.2017.07.012

13. 13.

    Piccolis M, et al. Probing the global cellular responses to lipotoxicity caused by saturated fatty acids. Mol. Cell. 2019;74:32-44.e38.

    Not in our library10.1016/j.molcel.2019.01.036

14. 14.

    Bandeira-Melo C, Weller PF, Bozza PT. Identifying intracellular sites of eicosanoid lipid mediator synthesis with EicosaCell assays. Methods Mol. Biol. 2011;717:277-289.

    Not in our library10.1007/978-1-61779-024-9_16

15. 15.

    Melo RC, Weller PF. Lipid droplets in leukocytes: organelles linked to inflammatory responses. Exp. Cell Res. 2016;340:193-197.

    Not in our library10.1016/j.yexcr.2015.10.028

16. 16.

    Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 2002;8:1235-1242.

    Not in our library10.1038/nm1102-1235

17. 17.

    Childs BG, et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016;354:472-477.

    Not in our library10.1126/science.aaf6659

18. 18.

    Kim K, et al. Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models. Circ. Res. 2018;123:1127-1142.

    Not in our library10.1161/circresaha.118.312804

19. 19.

    Cameron AM, et al. Inflammatory macrophage dependence on NAD. Nat. Immunol. 2019;20:420-432.

    Not in our library10.1038/s41590-019-0336-y

20. 20.

    Cao J, et al. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases. J. Biol. Chem. 2011;286:41838-41851.

    Not in our library10.1074/jbc.m111.245456

21. 21.

    Jaisinghani N, et al. Necrosis driven triglyceride synthesis primes macrophages for inflammation during. Front. Immunol. 2018;9:1490.

    Not in our library10.3389/fimmu.2018.01490

22. 22.

    Freigang S, et al. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat. Immunol. 2013;14:1045-1053.

    Not in our library10.1038/ni.2704

23. 23.

    Chandak PG, et al. Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. J. Biol. Chem. 2010;285:20192-20201.

    Not in our library10.1074/jbc.m110.107854

24. 24.

    Cogliati S, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell. 2013;155:160-171.

    Not in our library10.1016/j.cell.2013.08.032

25. 25.

    Buck MD, et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166:63-76.

    Not in our library10.1016/j.cell.2016.05.035

26. 26.

    Liepinsh E, et al. Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria. Biochem. J. 2016;473:1191-1202.

    Not in our library10.1042/bcj20160164

27. 27.

    Everts B, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation. Nat. Immunol. 2014;15:323-332.

    Not in our library10.1038/ni.2833

28. 28.

    Zasłona Z, et al. The induction of Pro-IL-1β by lipopolysaccharide requires endogenous prostaglandin E. J. Immunol. 2017;198:3558-3564.

    Not in our library10.4049/jimmunol.1602072

29. 29.

    O’Neill LAJ, Artyomov MN. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat. Rev. Immunol. 2019;19:273-281.

    Not in our library10.1038/s41577-019-0128-5

30. 30.
    A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation · 2018

    No notice
31. 31.

    Fuchs, A. L. et al. Quantitative. Metabolites9, 10.3390/metabo9110248 (2019).

    Not in our library

32. 32.

    Nguyen TB, et al. DGAT1-dependent lipid droplet biogenesis protects mitochondrial function during starvation-induced autophagy. Dev. Cell. 2017;42:9-21.e25.

    Not in our library10.1016/j.devcel.2017.06.003

33. 33.
    Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense · 2018

    No notice
34. 34.
    Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation · 2018

    No notice
35. 35.

    Violante S, et al. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines. FASEB J. 2013;27:2039-2044.

    Not in our library10.1096/fj.12-216689

36. 36.

    Rutkowsky JM, et al. Acylcarnitines activate proinflammatory signaling pathways. Am. J. Physiol. Endocrinol. Metab. 2014;306:E1378-E1387.

    Not in our library10.1152/ajpendo.00656.2013

37. 37.

    Nomura M, et al. Macrophage fatty acid oxidation inhibits atherosclerosis progression. J. Mol. Cell Cardiol. 2019;127:270-276.

    Not in our library10.1016/j.yjmcc.2019.01.003

38. 38.

    Malandrino MI, et al. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. Am. J. Physiol. Endocrinol. Metab. 2015;308:E756-E769.

    Not in our library10.1152/ajpendo.00362.2014

39. 39.

    Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur. J. Immunol. 2011;41:1203-1217.

    Not in our library10.1002/eji.201141550

40. 40.

    Divangahi M, et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 2009;10:899-906.

    Not in our library10.1038/ni.1758

Cited by papers we hold 4

• Graphene oxide exposure suppresses immune responses and increases the sensitivities of zebrafishes to lipopolysaccharides via the down-regulation of Toll-like receptors · 2022
  Not checked
• A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy · 2021
  Not checked
• Lipidomic Analyses Reveal Modulation of Lipid Metabolism by the PFAS Perfluoroundecanoic Acid (PFUnDA) in Non-Obese Diabetic Mice · 2021
  Not checked
• Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.